Lilly Settles Ark.'s Zyprexa Marketing Suit For $18.5M
Arkansas has struck an $18.5 million settlement in its suit against Eli Lilly & Co. over the alleged off-label promotion of schizophrenia drug Zyprexa, the state's attorney general announced Tuesday....To view the full article, register now.
Already a subscriber? Click here to view full article